TrialClinical rheumatology2024

Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study.

Christopher T Ritchlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.